menu
    • menu

    Company profile for Navinta

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Navinta, LLC is a privately held generic pharmaceutical company, established in 2003, dedicated to the development and commercialization of pharmaceutical products to treat patients with chronic and life-threatening diseases. Navinta means “novelty” inspiring a culture of transforming ideas into technology and advancing innovation to the marketplace with new medicines. Navinta has focused its research and regulatory activi...
    Navinta, LLC is a privately held generic pharmaceutical company, established in 2003, dedicated to the development and commercialization of pharmaceutical products to treat patients with chronic and life-threatening diseases. Navinta means “novelty” inspiring a culture of transforming ideas into technology and advancing innovation to the marketplace with new medicines. Navinta has focused its research and regulatory activities on developing new formulations, complex products, and unique pharmaceutical delivery systems. Navinta owns 21 process and product patents, 25 active Drug Master Files, and has 14 approved ANDA commercial products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NavintaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1499 Lower Ferry Road Ewing, NJ 08618
    Telephone
    Telephone
    +1 609.883.1135
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.navinta.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Navinta’s Generics Glycerol Phenylbutyrate Receive Approval in US
    Navinta’s Generics Glycerol Phenylbutyrate Receive Approval in US

    23 Apr 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220568

    FDA
    23 Apr 2026
    Share Share
    Everstone Invests $270M In Apothecon-Navinta Pharma Platform
    Everstone Invests $270M In Apothecon-Navinta Pharma Platform

    14 Apr 2026

    // BUSINESS STD

    https://www.business-standard.com/companies/news/everstone-capital-invests-270-million-in-apothecon-navinta-platform-126041400588_1.html

    BUSINESS STD
    14 Apr 2026
    Share Share
    Navinta’s Generics Sodium Phenylbutyrate Receives Approval in US
    Navinta’s Generics Sodium Phenylbutyrate Receives Approval in US

    17 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220418

    FDA
    17 Feb 2026
    Share Share
    Navinta’s Generics Diazepam Receives Approval in US
    Navinta’s Generics Diazepam Receives Approval in US

    14 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217468

    FDA
    14 Nov 2025
    Share Share
    Navinta’s Receives First Generic Approval for Diazepam in US
    Navinta’s Receives First Generic Approval for Diazepam in US

    14 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=217468

    FDA
    14 Nov 2025
    Share Share
    Navinta’s Generics Sevelamer Carbonate Receives Approval in US
    Navinta’s Generics Sevelamer Carbonate Receives Approval in US

    27 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219931

    FDA
    27 Oct 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Navinta and get a quotation

    Navinta is a supplier offers 9 products (APIs, Excipients or Intermediates).

    Find Cisatracurium Besylate bulk with DMF offered by Navinta

    Find Colesevelam Hydrochloride bulk with DMF offered by Navinta

    Find Crizotinib bulk with DMF offered by Navinta

    Find Diazepam bulk with DMF offered by Navinta

    Find Glycerol Phenylbutyrate bulk with DMF offered by Navinta

    Find Sodium Phenylbutyrate bulk with DMF offered by Navinta

    Find Tafamidis Meglumine bulk with DMF offered by Navinta

    Find Triheptanoin bulk with DMF offered by Navinta

    Find Remifentanil bulk offered by Navinta

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search